InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Runge Jeffrey W., Director. Insider active across 1 companies, notably Aditx Therapeutics, Inc.. In total, 2 filings have been published. Total volume traded: €3k. The latest transaction was filed on 1 June 2021 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
€1,682700 shares@ €2.4027100.0% of flow
Common Stock
SEC:0001213900-21-030618·
Ideal exit: 26 Feb 2022 (T+270)
€1,682700 shares@ €2.402779.45% mcap50.0% of flow
Common Stock
SEC:0001213900-21-030618:0·
Ideal exit: 26 Feb 2022 (T+270)
2 of 2 declarations
About Runge Jeffrey W.
Jeffrey W. Runge is a Board Member at Aditx Therapeutics, Inc. In this role, he actively participates in board discussions and contributes to strategic decision-making. His experience in the biopharmaceutical sector allows him to make significant contributions to board discussions. He is committed to promoting best governance practices and ensuring the company's sustainability.
